64818-79-7

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2-amino-3-methylbenzoate is used as an intermediate in the synthesis of various drugs and medications. Its unique structure and properties make it a potential building block for the development of new therapeutic agents.
Used in Antifungal Applications:
Ethyl 2-amino-3-methylbenzoate is used as an antifungal agent due to its ability to inhibit the growth of fungi, making it a promising candidate for the development of new antifungal drugs.
Used in Antimicrobial Applications:
Ethyl 2-amino-3-methylbenzoate is used as an antimicrobial agent due to its ability to inhibit the growth of bacteria, making it a valuable component in the development of new antimicrobial drugs and treatments.

InChI:InChI=1/C10H13NO2/c1-3-13-10(12)8-6-4-5-7(2)9(8)11/h4-6H,3,11H2,1-2H3

Upstream product

• 64-17-5 ethanol 
• 4389-45-1 3-methylantranilic acid 

Downstream Products

• 885278-74-0 ethyl 1H-indazole-7-carboxylate 
• 145440-96-6 N-(2-methyl-6-hydroxymethylphenyl)-5-methyl-3-isoxazolecarboxamide 
• 145440-92-2 3-Methyl-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-benzoic acid ethyl ester 
• 59689-18-8 2-(2-amino-3-methylphenyl)propan-2-ol 

Relevant academic research and scientific papers

Overcoming the Deallylation Problem: Palladium(II)-Catalyzed Chemo-, Regio-, and Stereoselective Allylic Oxidation of Aryl Allyl Ether, Amine, and Amino Acids

We report herein a Pd(II)/bis-sulfoxide-catalyzed intramolecular allylic C-H acetoxylation of aryl allyl ether, amine, and amino acids with the retention of a labile allyl moiety. Mechanistically, the reaction proceeds through a distinct double-bond isomerization from the allylic to the vinylic position followed by intramolecular carboxypalladation and the β-hydride elimination pathway. For the first time, C-H oxidation of N-allyl-protected amino acids to furnish five-membered heterocycles through 1,3-syn-addition is established with excellent diastereoselectivity.

New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents

We prepared a series of N-aryl isoxazolecarboxamide, N-isoxazolylbenzamide compounds and derivatives and studied their anticonvulsant action in MES and MMS tests. Some of these reveal considerable activity, especially with respect to MES test. The disubstitution in the 2.6-position on the phenyl ring by two methyl groups would appear to be of primary importance for the activity. The amide bridge between the phenyl and isoxazolic rings, whether of the anilide or benzamide type, seems to show similar anticonvulsant behavior. We have selected the derivatives 8 (N-(2.6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide, 12 (N-(2.6-dimethylphenyl)-5-hydroxymethyl-3-isoxazolecarboxamide) and 51 (N-(5-methyl-3-isoxazolyl)-2.6-dimethylbenzamide) which are presently being studied in more extended pharmacological tests.